Cardlytics

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cardlytics reports robust Q4 performance and eyes positive cash flow

Cardlytics delivered a strong performance in Q4 2022, marked by robust financial results and operational improvements.
The company's strategic focus on cost management, product enhancements, and consumer engagement bodes well for future growth.
While facing challenges in a competitive landscape, Cardlytics is poised to capitalize on opportunities through innovation and strategic initiatives.
Guidance for Q1 2023 and the target for positive free cash flow in Q3 2023 reflect a positive outlook for the company's financial health.

Cardlytics (CDLX) surpasses Q1 expectations amidst cautious advertiser sentiment

Cardlytics (CDLX) reported strong Q1 2023 earnings, exceeding expectations with growth in unique consumers activating offers and improved cost discipline.
The company faces challenges from cautious advertisers and client concentration risks, requiring strategic management and diversification efforts.
Opportunities for growth include expanding the partner network, driving user engagement, and innovating in product offerings to maintain competitiveness.

Cardlytics reports mixed Q2 results, eyes partnerships for growth

Cardlytics navigated mixed financial results in Q2 2023, focusing on cost optimizations and strategic initiatives. The company aims for positive annual adjusted EBITDA and operating cash flow in 2024 amidst market variability and economic uncertainty.

Cardlytics reports positive Q3 results, eyes global expansion and new products

Cardlytics delivered positive Q3 results, showcasing growth in revenue, partnerships, and strategic initiatives. Challenges include revenue factors and product adoption, while opportunities exist in new product offerings and global expansion. The company remains optimistic about future prospects and business success.

Cardlytics reports record Q4 earnings, eyes growth through redemptions

Cardlytics achieved a milestone with its first positive annual adjusted EBITDA since 2019 and recorded its largest adjusted EBITDA in Q4. The company is strategically positioned for growth with new partnerships, product launches, and a focus on driving redemptions. Challenges lie in maintaining financial performance and capital structure.

Cardlytics (CDLX) posts robust Q1 results, eyes growth opportunities

Cardlytics (CDLX) reported strong Q1 2024 results with notable billings and revenue growth, positive adjusted EBITDA, and progress in strategic initiatives. While facing challenges in Q2 projections and analyst inquiries, the company remains focused on capitalizing on growth opportunities and market trends.

Cardlytics reports mixed Q2 results, focuses on growth opportunities

Cardlytics shows resilience with positive adjusted EBITDA in 2023 and improved financial stability
Despite missing Q2 guidance, the company is addressing delivery issues and focusing on growth areas
Strong relationships with financial institutions and plans for business evolution under new leadership
Q3 outlook includes challenges but also opportunities for expansion and performance acceleration

Cardlytics faces Q3 revenue decline, eyes growth through strategic investments

Cardlytics navigated Q3 challenges with a focus on enhancing key aspects of its business. The company's strategic priorities include supply, demand, network performance, and investments in growth initiatives like Bridg and Rippl.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Cardlytics is down over 20% as a result of earnings. I continue to believe in the company's long-term potential and believe that this dip is overdone.

Cardlytics: A Buying Opportunity

Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q2 2021 Results - Earnings Call Transcript

Shares of Cardlytics Inc. were clobbered in extended trading Tuesday, plunging 23% after the digital-advertising platform reported fiscal second-quarter results. Cardlytics reported a net loss of $47.3 million, or $1.43 a share, compared with a net loss of $19.8 million, or 73 cents a share, in the year-ago quarter.

Cardlytics shares plunge 23% on Q2 results

ATLANTA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2021. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.

Cardlytics Announces Second Quarter 2021 Financial Results

Cardlytics (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Cardlytics (CDLX) Report Negative Earnings Next Week? What You Should Know

ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced that its second quarter ended June 30, 2021 financial results will be released on Tuesday, August 3, 2021, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Cardlytics Announces Timing of Its Second Quarter 2021 Financial Results Conference Call and Webcast

Chewy

Block

ZoomInfo Technologies

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Chewy & Square.

Major upside could be in store for these stocks, according to Wall Street's best-performing analysts

Former Amazon and Yahoo Executive With 20+ Years in Advertising Tech Experience  Leads Cardlytics' Ad Platform Evolution

Cardlytics Announces Peter Chan as Chief Technology Officer

Executive team presentations will showcase activation strategies and opportunities for continued growth Executive team presentations will showcase activation strategies and opportunities for continued growth

Save-the-Date Reminder for Cardlytics' Virtual Investor Day on June 10

ATLANTA, June 02, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it will present at the BofA Securities 2021 Global Technology Conference.

Cardlytics to Present at the BofA Securities 2021 Global Technology Conference

ATLANTA, May 18, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, announced today that it will host a virtual Investor Day on Thursday, June 10, 2021.The company's executive team is scheduled to begin presentations at 9:30 a.m. ET. Presenting executives include:

Cardlytics to Host Virtual Investor Day on June 10

ATLANTA, May 14, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it will present at the 16th Annual Needham Virtual Technology & Media Conference.

Cardlytics to Present at the 16th Annual Needham Virtual Technology & Media Conference

ATLANTA, May 05, 2021 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), one of the largest digital advertising platforms, announced today the completion of its acquisition of Bridg, a customer data platform. Previously announced on April 13, the acquisition pairs Cardlytics' advertising platform, with visibility into one in every two card swipes in the U.S., with Bridg's enhanced SKU-level insights. Together, the combined capabilities are expected to power a more comprehensive view of consumer purchase behavior, accelerating the creation of a holistic, results-driven, self-serve, always-on advertising solution for brands.

Cardlytics Completes Acquisition of Bridg

Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q1 2021 Results - Earnings Call Transcript

ATLANTA, May 04, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced financial results for the first quarter ended March 31, 2021. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.

Cardlytics Announces First Quarter 2021 Financial Results

ATLANTA, April 20, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2021 financial results will be released on Tuesday, May 4, 2021, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

Cardlytics Announces Timing of Its First Quarter 2021 Financial Results Conference Call and Webcast

The stock price of Cardlytics Inc (NASDAQ: CDLX) increased by 13.91%. This is why it happened.

CDLX Stock: 13.91% Increase Explanation

Novocure

Twitter

Berry Petroleum Corp.

Global Blood Therapeutics

OrganiGram Holdings Inc.

Synchrony Financial

Atlassian

YUM! Brands

With the trading day about halfway over, the broad markets were again somewhat mixed.

NovoCure, Synchrony, Twitter, Yum! and More Wednesday Afternoon Analyst Calls

Cardlytics Inc (NASDAQ: CDLX) announced its intent to acquire customer data platform Bridg for $350 million in cash to expand Cardlytics' advertising platform with Bridg's SKU-level insights and consumer engagement capabilities across other digital platforms. Additionally, Cardlytics has agreed to two potential earnout payments in cash and stock worth $100 million to $300 million on the first and second year of the closing based on Bridg's U.S. annualized revenue run rate.

Cardlytics To Acquire Data Platform Bridg For $350M

Cardlytics (NASDAQ: CDLX) announced today that it is going to buy Bridg for approximately $350 million in cash at closing. These are the details.

Cardlytics (CDLX) Buying Bridg For $350 Million

Marketers Will Gain Unprecedented Ability to Understand and Reach Consumers with Bridg SKU Data and Cardlytics' Advertising Platform Marketers Will Gain Unprecedented Ability to Understand and Reach Consumers with Bridg SKU Data and Cardlytics' Advertising Platform

Cardlytics to Acquire Bridg to Accelerate Transformational Growth

Laureate Education

NanoString Technologies

TripAdvisor

United States Steel

Just as quickly as Nasdaq ﻿NDAQ﻿ hit correction territory twice in the last week, it saw sharp gains. Meanwhile, Q.ai's deep learning algorithms have brought you today's top shorts.

Top Stocks To Short Today As Nasdaq Pops Again

Arvinas Inc

Redfin

Sabre

Workhorse Group

Bond yields are rising again, crushing tech stocks. But the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts for today.

Today's Top Shorts As Tech Stocks Lag With More Rising Bonds

ATLANTA, March 02, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $500.5 million. The offering is expected to close on or about March 5, 2021, subject to customary closing conditions. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 577,500 shares of common stock at the public offering price, less underwriting discounts and commissions.

Cardlytics Announces Pricing of Public Offering of Common Stock

ATLANTA, March 01, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that it has commenced an underwritten public offering of $500 million of shares of common stock. All of the shares of common stock to be sold in the offering will be offered by Cardlytics. In addition, Cardlytics expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

News for Cardlytics Stock (CDLX)